Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Rocchi

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Thyroid : Official Journal of the American Thyroid Association|August 29, 2013
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisitedFrancesca Menconi, Maria Antonietta Profilo, Marenza Leo, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2015
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral centerMarenza Leo, Francesca Menconi, Roberto Rocchi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 20, 2015
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' OrbitopathyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trialMarenza Leo, Claudio Marcocci, Aldo Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
Journal of Endocrinological Investigation|March 21, 2025
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimusSimone Comi, Giada Cosentino, Elena Sabini, et al.
Thyroid : Official Journal of the American Thyroid Association|October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfactionRoberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2018
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional StudyElena Sabini, Barbara Mazzi, Maria Antonietta Profilo, et al.
European Journal of Endocrinology|February 10, 2015
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological studyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Long-term safety of orbital radiotherapy for Graves' ophthalmopathyClaudio Marcocci, Luigi Bartalena, Roberto Rocchi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Thyroid : Official Journal of the American Thyroid Association|August 29, 2013
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisitedFrancesca Menconi, Maria Antonietta Profilo, Marenza Leo, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2015
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral centerMarenza Leo, Francesca Menconi, Roberto Rocchi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 20, 2015
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' OrbitopathyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trialMarenza Leo, Claudio Marcocci, Aldo Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
Journal of Endocrinological Investigation|March 21, 2025
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimusSimone Comi, Giada Cosentino, Elena Sabini, et al.
Thyroid : Official Journal of the American Thyroid Association|October 18, 2012
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfactionRoberto Rocchi, Riccardo Lenzi, Michele Marinò, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2018
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional StudyElena Sabini, Barbara Mazzi, Maria Antonietta Profilo, et al.
European Journal of Endocrinology|February 10, 2015
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological studyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Long-term safety of orbital radiotherapy for Graves' ophthalmopathyClaudio Marcocci, Luigi Bartalena, Roberto Rocchi, et al.
Pageof 4